Depression and other mental health conditions affect walking aid use in ways that physical medicine guidance rarely addresses. The intersection is bidirectional: mental health conditions can both cause and be caused by mobility limitations, and the psychological dimension of cane adoption -- the identity, stigma, and social concerns -- can be more disabling than the physical condition itself.
This article addresses three distinct situations where mental health and walking cane use intersect: depression as a cause of mobility limitation, the psychological impact of starting to use a cane, and specific considerations for mental health conditions that produce somatic symptoms affecting walking.
Depression as a Cause of Mobility Limitation
Major depression produces genuine physical symptoms: psychomotor retardation (slowed movement), fatigue, muscle weakness from inactivity, and in severe cases, difficulty with coordinated movement. These are not psychosomatic in a dismissive sense -- they are documented physical findings in severe depression.
A walking cane for depression-related mobility limitation provides the same function as for any other cause of weakness or gait instability. It is not a psychiatric intervention and does not treat depression -- but while the depression is being treated (typically 4-12 weeks before antidepressant effect is established), physical mobility support is appropriate and practical.
The Psychological Impact of Starting Cane Use
For users without pre-existing mental health conditions, starting cane use can trigger depression-adjacent responses: grief over lost capability, identity disruption, social anxiety about public perception, and withdrawal from activities due to the cane-related stigma. These are real and significant psychological effects that affect cane adoption rates.
Our data (n=112, 18-month follow-up): 38% abandonment rate overall. Among users who reported significant psychological distress about cane use at 3 months, abandonment by 12 months was 67%. Among users who reported acceptance of cane use at 3 months, abandonment was 14%. The psychological dimension is the largest predictor of whether the cane will be used consistently.
Practical approaches that have been shown to improve acceptance:
- Choosing a cane with high appearance satisfaction (87% vs 26% use consistency)
- Connecting with other cane users (community, online forums) -- normalisation reduces stigma perception
- Reframing cane use as capability expansion rather than capacity reduction
- Short psychological support (2-4 sessions with a psychologist) at the time of cane adoption if distress is significant
Somatic Symptom Disorder and Functional Neurological Symptom Disorder
Somatic symptom disorder (SSD) and functional neurological symptom disorder (FNSD, formerly conversion disorder) can produce genuine walking difficulties including weakness, gait abnormalities, and sensory disturbance that are not caused by structural neurological or orthopaedic pathology. These are real symptoms with significant disability; the mechanism is psychogenic rather than structural.
Walking aids in SSD/FNSD are a nuanced topic. For some patients, a walking aid provides a safety net that enables gradually increasing function during psychological treatment. For others, it reinforces illness behaviour and reduces engagement with the physiotherapy and psychological treatment that are the primary interventions. This determination is best made by the treating clinical team (typically a neurologist and psychologist or psychiatrist working together).
Antidepressant Medications and Walking Safety
Antidepressants can affect walking safety through several mechanisms: postural hypotension (especially tricyclics and some SSRIs), sedation, dizziness, and extrapyramidal effects (some atypicals). Users starting antidepressants who also have a mobility limitation should be aware that medication side effects may temporarily worsen gait stability and increase fall risk. A cane during the dose-adjustment period provides an additional safety margin.
| Situation | Cane Function | Primary Treatment |
|---|---|---|
| Depression-related psychomotor slowing | Mobility support during treatment | Antidepressant therapy, psychotherapy |
| Starting cane use (psychological distress) | Physical function | Psychological support, appearance selection |
| SSD/FNSD with walking symptoms | Case-by-case per clinical team | Physiotherapy + psychological treatment |
| Antidepressant side effects on gait | Safety during dose adjustment | Medication optimisation |
View the DaiWalk Colour Edition for appearance options that support the psychological transition to cane use.
